TraceLink unveils EU FMD Express

11 Apr 2018

Purpose-built compliance solution for smaller pharmaceutical companies.

TraceLink has launched EU FMD Express – a cost-effective, simplified solution designed specifically to address the needs of smaller pharmaceutical companies complying with the EU Falsified Medicines Directive (FMD.)

TraceLink unveils EU FMD Express

With far greater resource and budget constraints than their larger counterparts, many small pharmaceutical companies face extreme challenges with serialization, including master data management and data exchange with their CMOs, making it difficult to meet the EU FMD deadline by February 2019.

TraceLink’s EU FMD Express provides these companies with a simple approach to meet EU FMD compliance while controlling costs and minimizing business impact. With over 40,000 users regularly accessing the Life Sciences Cloud system, TraceLink’s EU FMD Express is a complete, easy to use solution that allows smaller manufacturers to comply with EU FMD and integrate with the EU Hub through a single, secure connection, while removing the burden of software maintenance and upgrades, and insulating companies from regulatory changes.

“Due to its size and vast number of companies spread across various countries, Europe is one of the largest and most complex markets, leaving hundreds of small companies grappling with how to achieve EU FMD compliance within the next 11 months,” said Shabbir Dahod, president and CEO, TraceLink. “As the market leader, we feel that is our responsibility to help every company comply, regardless of size, and therefore developed this cost-effective, easy to use offering to streamline the ability for smaller companies to become compliant on time, with no disruption to their business operations. Through our investment in services and support in the EU and unique network architecture to accelerate company on-boarding, TraceLink is the only company positioned to provide such an offering for this market.”

EU FMD Express: key benefits for small pharmaceutical companies

Designed specifically for smaller pharmaceutical companies with simple supply chains, EU FMD Express utilizes purpose-built templates and compliance modules for faster implementation and predictable costs. TraceLink executes the entire deployment, including system configuration and data entry. Every EU FMD Express customer will benefit from the following:
  • Easy to Use and Proven Solution That Is Purpose-Built for Smaller Companies – Enabling portal access for line management systems and CMOs with integration options available; access to TraceLink’s serial number and event repository; and direct integration into the EU Hub.
  • Simplified Deployment, Set-Up and Configuration – TraceLink Services will help EU FMD Express customers define and manage their master data, on-board and train their CMOs, configure the EU compliance module, support for QA testing and validation, and user training.
  • Ongoing Training and Education – All EU FMD Express users will have full access to TraceLink configuration templates for master data and serial number templates. TraceLink also provides an online collaboration workspace for companies to exchange customer configuration documents and full access to TraceLink University for tutorials and e-learning courses.
  • Read More

    Related news

    Specialist API CDMO acquired by GHO Capital

    Specialist API CDMO acquired by GHO Capital

    16 Mar 2019

    Future plan is to extend Sterling’s international presence to meet increasing demand from customers worldwide.

    Read more 
    Bringing next generation single-use sensor technologies to the life science market

    Bringing next generation single-use sensor technologies to the life science market

    14 Mar 2019

    Pall and Broadley-James’ combined expertise proves complementary in addressing critical customer pain points in modern bioprocessing.

    Read more 
    Third Sartorius Research Xchange Forum 2019 focuses on CAR-T cell therapy

    Third Sartorius Research Xchange Forum 2019 focuses on CAR-T cell therapy

    13 Mar 2019

    Event for experts from academia and industry, including talks, live demo sessions, and panel discussion.

    Read more 
    TraceLink submits an interoperable blockchain network solution for FDA DSCSA Pilot Project Program

    TraceLink submits an interoperable blockchain network solution for FDA DSCSA Pilot Project Program

    12 Mar 2019

    Trace Histories is a purpose-built distributed ledger solution for ensuring patient safety by 2023 DSCSA deadline.

    Read more 
    Overcoming lyophilization challenges at Interphex 2019

    Overcoming lyophilization challenges at Interphex 2019

    10 Mar 2019

    Line of Sight approach to freeze-drying enables organizations to bring pharmaceutical products safely and quickly to market.

    Read more 
    Catalent invests over $27 million to commercialize Zydis Ultra

    Catalent invests over $27 million to commercialize Zydis Ultra

    7 Mar 2019

    Zydis Ultra allows a patented and innovative drug coating to be introduced during a product’s formulation, enabling the dosage of active ingredient to be up to four times higher than a conventional Zydis ODT.

    Read more 
    Novel systems for membrane chromatography

    Novel systems for membrane chromatography

    6 Mar 2019

    Optimally run membrane chromatography processes will provide higher productivity, smaller-scale operations and increased robustness.

    Read more 
    Lilly to introduce lower-priced insulin

    Lilly to introduce lower-priced insulin

    5 Mar 2019

    Authorized generic version of Humalog will be available in US pharmacies at 50% lower list price.

    Read more 
    Biogen acquisition boosts its ophthalmology pipeline

    Biogen acquisition boosts its ophthalmology pipeline

    4 Mar 2019

    Nightstar Therapeutics has two potentially first-in-class mid- to late-stage clinical assets as well as preclinical programs.

    Read more 
    Uniqsis expands LED photoreactor range

    Uniqsis expands LED photoreactor range

    3 Mar 2019

    The availability of three new alternative switchable LED configurations provides chemists with the unique ability to optimally undertake almost any photochemistry reaction.

    Read more